The Co-Sponsor in the conduct of a Clinical Trial in Germany

The sponsor is highly relevant in the conduct of clinical trials, both from a financial point of view and in terms of responsibility for study management. Until now, only one sponsor was designated as the primary contact for the conduct of clinical trials. The new regulation (EU) No 536/2014 allows the use of multiple sponsors, so-called co-sponsors. But this also raises new problems and questions for existing contracts and new contracts between sponsors, especially regarding the liability of one or more co-sponsors in the external as well as the internal relationship. This article highlights the issues arising from this amendment and clarifies the differences between a sponsor and a co-sponsor.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Regulatory Affairs
Published
2024-09-15
DOI
https://doi.org/10.22270/ijdra.v12i3.666
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Co-Sponsor in the conduct of a Clinical Trial in Germany

Christoph Gerst, Raees Ahmed, Simge Süngü
International Journal of Drug Regulatory Affairs
Biomedical Ethics and Regulation
article

The Co-Sponsor in the conduct of a Clinical Trial in Germany

Christoph Gerst, Raees Ahmed, Simge Süngü
article en

Abstract

The sponsor is highly relevant in the conduct of clinical trials, both from a financial point of view and in terms of responsibility for study management. Until now, only one sponsor was designated as the primary contact for the conduct of clinical trials. The new regulation (EU) No 536/2014 allows the use of multiple sponsors, so-called co-sponsors. But this also raises new problems and questions for existing contracts and new contracts between sponsors, especially regarding the liability of one or more co-sponsors in the external as well as the internal relationship. This article highlights the issues arising from this amendment and clarifies the differences between a sponsor and a co-sponsor.

International Journal of Drug Regulatory AffairsVol. 12(3)
Universitätsmedizin Göttingen (DE)
Openalex Percentile: Top 76%
Biomedical Ethics and Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.